Jiang Ma

Jiang Ma

Auto-generated profile, based on publicly available information

Jiang Ma

School of Chinese Materia Medica

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2019 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
JMJiang Ma
Jiang Ma
JRJianqing Ruan
Jianqing Ruan
XCXinmeng Chen
Xinmeng Chen
DLDongping Li
Dongping Li
SYSheng Yao
Sheng Yao
GLGe Lin
Ge Lin

18 November 2020 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
JMJiang Ma
Jiang Ma
WZWei Zhang
Wei Zhang
YHYisheng He
Yisheng He
LZLin Zhu
Lin Zhu
CZChunyuan Zhang
Chunyuan Zhang
GLGe Lin
Ge Lin

2 April 2020 in Journal of Environmental Science and Health, Part C
Verified
Journal Article
Closed access
ZSZijing Song
Zijing Song
YHYisheng He
Yisheng He
JMJiang Ma
Jiang Ma
PFPeter P. Fu
Peter P. Fu
GLGe Lin
Ge Lin
The hepatotoxic pyrrolizidine alkaloids (PAs) are metabolically activated in the liver to form reactive dehydro-PAs, which generate pyrrole-protein adducts leading to hepatotoxicity. Monocrotaline, but not other PAs, is also pneumotoxic, supposedly due to the migration of the liver-generated corresponding dehydro-PA into the lung to form pyrrole-protein adducts to induce pneumotoxicity. The present study investigated whether other PAs are also pneumotoxic. Metabolic activation of four representative hepatotoxic PAs, monocrotaline, retrorsine, riddelliine and clivorine, was investigated using rat liver or lung S9 incubation. All PAs produced pyrrole-protein adducts significantly in rat liver S9 but negligible in lung S9 fraction, revealing that liver is the key organ responsible for metabolic activation generating dehydro-PAs. Furthermore, these four PAs and another two PAs present in the alkaloid extract of Gynura segetum, a widely used PA-producing herb responsible for human PA poisonings in China, were orally administered to rats using the same hepatotoxic dose of 0.2 mmol/kg. All six PAs induced pneumotoxicity in rats within 48 h. The results demonstrated that pneumotoxicity could be a common phenomenon of PAs and the liver-derived dehydro-PAs might move to the lung and form pyrrole-protein adducts, leading to pulmonary toxicity.

13 May 2022 in Phytomedicine
Verified
Journal Article
Closed access
CWCindy WANG
Cindy WANG
JMJiang Ma
Jiang Ma
YHYisheng He
Yisheng He
KMKai-Kei Miu
Kai-Kei Miu
SYSheng Yao
Sheng Yao
GLGe Lin
Ge Lin

1 August 2021 in Phytomedicine
Verified
Journal Article
Closed access
XCXinmeng Chen
Xinmeng Chen
JMJiang Ma
Jiang Ma
YHYisheng He
Yisheng He
JXJunyi Xue
Junyi Xue
ZSZijing Song
Zijing Song
GLGe Lin
Ge Lin

2 April 2020 in Journal of Environmental Science and Health, Part C
Verified
Journal Article
Closed access
YLYao Lu
Yao Lu
KWKa Yan Wong
Ka Yan Wong
CTChunlai Tan
Chunlai Tan
JMJiang Ma
Jiang Ma
BFBo Feng
Bo Feng
GLGe Lin
Ge Lin
Pyrrolizidine alkaloids (PAs) are extensively distributed in plants and are known to damage hepatic sinusoidal endothelial cells (HSECs) via metabolic activation mediated by hepatic cytochrome P450 enzymes (CYPs), particularly the CYP3A4 isozyme. Different PAs have distinct toxic potencies and their toxic effects on HSECs are difficult to be determined in cultured cells, because HSECs lack the key CYP3A4 isozyme for metabolic activation. This study aims to establish a novel, convenient and reliable CYP3A4-expressing HSEC model using human HSECs transduced with lentivirus carrying CYP3A4-ires-eGFP, for evaluating the hepatotoxicity of different PAs on their target HSECs. The developed CYP3A4-expressing HSEC (HSEC-CYP3A4) model was verified by the expression of GFP and CYP3A4 and by the ability to metabolize nifedipine, a classic CYP3A4 substrate. Treated with retrorsine, a representative toxic PA, HSEC-CYP3A4 cells showed significantly reduced cell viability, depletion of GSH, and increased formation of pyrrole-protein adducts. Furthermore, this newly developed cell model successfully discriminated the cytotoxic potency of different PAs evidenced by their IC40 values. In conclusion, the established HSEC-CYP3A4 cell model can be used as a rapid screening platform for assessing the relative potencies of individual PAs on their target HSECs and for investigating the mechanisms underlying PA-induced hepatic sinusoidal damage.